Last reviewed · How we verify

NCT04376619

Preventing Acute Kidney Injury

Withdrawn NA Last updated 22 October 2021
What this trial tests

NA trial testing remote ischemic preconditioning in Acute Kidney Injury. Withdrawn.

Timeline
1 August 2020
Primary endpoint
1 April 2021
1 August 2021

Quick facts

Lead sponsorAtlantic Health System
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationnon randomized
Designsequential
Maskingnone
Primary purposeprevention
Start date1 August 2020
Primary completion1 April 2021
Estimated completion1 August 2021

Drugs / interventions tested

Conditions studied

Sponsor

Atlantic Health System — full company profile →

Who can join

18 and older, any sex, with Acute Kidney Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute kidney injury increases the risk for chronic kidney disease, length of stay, readmissions and mortality. Currently the only way to diagnose acute kidney injury is with a serum creatinine or drop in urine output. Biomarkers for acute kidney injury are well elevated before rise in creatinine. Hypothesis is that by implementing an electronic alert system with an algorithm followed by remote ischemic preconditioning will prevent acute kidney injury.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of remote ischemic preconditioning

Trials testing the same drug.

Other recruiting trials for Acute Kidney Injury

Currently open trials in the same condition.

Other Atlantic Health System trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04376619.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing